Theriva Biologics, Inc. recently disclosed the outcomes of a Type D meeting with the U.S. Food and Drug Administration (FDA), outlining details regarding the design of a Phase 3 clinical study ...
December 2024 - The VinFuture Foundation has honored four scientific breakthroughs in 2024. The US$3 million Grand Prize is awarded to "transformational ...